Multicenter experience with photoselective vaporization of the prostate on men taking novel oral anticoagulants
作者机构:Bankstown-Lidcombe HospitalSydneyAustralia Clinique PasteurToulouseFrance Massacheussets General HospitalBostonUSA The Chris O’Brien Lifehouse HospitalSydneyAustralia
出 版 物:《Asian Journal of Urology》 (亚洲泌尿外科杂志(英文))
年 卷 期:2020年第7卷第4期
页 面:340-344页
学科分类:1002[医学-临床医学] 100210[医学-外科学(含:普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 10[医学]
主 题:Benign prostatic hyperplasia Benign prostatic obstruction Photoselective vaporisation of the prostate Non-vitamin K oral anticoagulants Novel oral anticoagulants
摘 要:Objective:Photoselective vaporization of the prostate(PVP)is a widely performed surgical procedure for benign prostatic *** approach has become particular favoured for men on anti-platelet and anticoagulation agents such as clopidogrel and warfarin but there is minimal published experience in the setting of novel oral anticoagulants(NOACs).This study was to examine the perioperative outcomes in men on NOACs undergoing PVP,with particular reference to perioperative ***:A retrospective analysis of PVP datasets was undertaken from three centres in Sydney(Australia),Toulouse(France)and Boston(USA).Subjects who had been treated whilst on NOACs without discontinuation or bridging were *** outcomes and treatment parameters were examined and morbidity recorded according to Clavien-Dindo(CD)***:There were a total of 20 subjects who had undergone PVP whilst NOACs had been continued during the perioperative *** mean age was 776.5 *** mean prostate volume,energy utilization and vaporisation time was 9456 mL,301211 kJ,and 3521 min *** mean postoperative duration of catheterization and duration of hospitalization was 2.22.4 days and 2.42.4 days *** was a single episode of urinary tract infection and four subjects required re-catheterisation for non-hematuric ***:This study supports the safety of men on NOACs undergoing *** this study represents the largest experience of PVP in these men,larger studies are necessary to confirm the safety of PVP in this group of men undergoing BPH-related surgery.